TSX closed
Loading markets…

Advertisement

Stocks

Curaleaf Holdings Inc. (CURA.TO) Surges 10% After FTSE Canada All Cap Index Inclusion

By Qayyum Rajan, CFA -

Follow live quotes and coverage.

Stocks & ETFs:CURA.TO

Follow CURA

Photos provided by Pexels

Curaleaf Holdings Inc. saw a notable 10% gain over the past week, buoyed by its recent addition to the FTSE Canada All Cap Index. This milestone marks a significant step in increasing the company’s visibility among institutional investors.

Over the last week, Curaleaf has gained 10%, driven by its inclusion in the FTSE Canada All Cap Index effective September 18, 2026. This addition follows the company's earlier entry into the S&P/TSX Composite Index in 2025, expanding its reach to a broader base of institutional funds and enhancing liquidity. As Curaleaf continues to establish its presence in the cannabis market, investors are taking notice.

Investor takeaway: Curaleaf's recent index inclusion may attract more institutional investment, positioning the company for potential growth.

Advertisement

Curaleaf Holdings Inc.

CURA.TO

Full stock page →

CURA.TO

Curaleaf Holdings Inc.

Source:WealthAwesomeWealthAwesome
↑ $6.72 (66.67%)
120 day period
$9.39$13.10$16.80Apr 2Jun 29Sep 23

Market cap

$4.45B

52W high

$20.93

52W low

$7.77

1W change

+19.91%

Beta

1.64

Analyst Price Targets

Based on analyst covering CURA · as of Sep 24, 2026

📈

Wall Street analysts forecast CURA stock price to rise 11.6% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$18.74

+11.6% Upside

Previously C$18.71 on Sep 23, 2026

Current Price

C$16.80

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CURA's historical volatility

HistoricalForecast68%95%
C$10.36C$16.07C$21.77C$27.48C$33.18C$38.89TodayMay 15Jul 21Sep 23Nov 5Dec 19Jan 31

30-Day Vol

52.8%

Annualized

90-Day Vol

61.0%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$20.08

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$17.83C$14.86 – C$21.39
60 trading daysC$18.92C$14.63 – C$24.49
90 trading daysC$20.08C$14.65 – C$27.54

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Curaleaf's Index Inclusion: A Catalyst for Growth?

Curaleaf's market cap stands at CA$4.45 billion, and its recent performance reflects a growing interest in its stock following the FTSE index announcement. With a forward P/E of 138.89x, the stock is priced for growth, but investors should remain cautious given its current loss per share.

Bull case

  • Being included in the FTSE Canada All Cap Index could lead to more liquidity and a wider shareholder base.
  • Increased visibility among institutional investors may boost future stock performance.
  • Curaleaf's established presence in the cannabis sector positions it well for long-term growth.

Bear case

  • The cannabis sector is still volatile, and Curaleaf's financials show a negative profit margin and a high forward P/E ratio.
  • Market conditions and regulatory changes could affect future growth and profitability.
  • Rising competition in the cannabis space may challenge Curaleaf's market position.

Why Curaleaf's Index Inclusion Matters

Advertisement

Curaleaf's addition to the FTSE Canada All Cap Index is a pivotal moment for the company. This inclusion not only boosts its visibility but also opens doors to a wider range of institutional investors. As passive and active funds begin to take notice, Curaleaf could see increased trading volume and interest, which may positively influence its stock price in the long run.

Market Reaction to Curaleaf's Performance

The cannabis sector has faced scrutiny, yet Curaleaf's recent performance indicates a positive market response. Investors seem optimistic about the company's growth trajectory, especially as it continues to expand its footprint in Canada and beyond. However, potential investors should balance this optimism with the industry's inherent volatility.

What Lies Ahead for Curaleaf

Looking forward, Curaleaf's ability to capitalize on its index inclusion will depend on its operational performance and market conditions. Investors should keep an eye on upcoming financial reports and any strategic initiatives that the company may announce, as these will be crucial in determining its future growth and stock performance.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 24, 2026
Last Updated: September 24, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement